Group 1: Wastewater Resource Utilization - The company focuses on wastewater resource utilization as a core business area, with significant breakthroughs in membrane technology and process innovation [2] - The fifth generation of MBR membrane modules has been developed, with the V-MBR technology achieving independent intellectual property rights and large-scale demonstration projects [2] - A representative project, the Meixi Lake Water Purification Plant, has a design capacity of 250,000 tons/day and was recognized as a national green low-carbon benchmark water plant in 2024 [2] Group 2: Industrial Water Treatment and Seawater Utilization - The company has successfully implemented multiple key projects in industrial water treatment, including projects in Liaoning and Shandong, showcasing its technical strength [3] - In seawater desalination, the company has achieved international leading levels in membrane product technology, with a desalination rate of 99.8% for the UF-RO dual membrane integration technology [3] - The integrated seawater utilization project in Huanghua City has a total investment of over 500 million RMB, combining water intake, pretreatment, desalination, and photovoltaic energy storage systems [3] Group 3: Salt Lake Resource Utilization - The company has made significant progress in salt lake resource utilization, developing six specialized adsorbents/membrane products and five integrated technologies [3] - The lithium extraction project at Zijin Mining's Tibet Arilagocuo Salt Lake has an annual capacity of 20,000 tons of lithium hydroxide, marking a global first for the "titanium-based adsorbent + membrane system" [3] - Future plans include expanding from salt lake resources to industrial valuable resource recovery and comprehensive utilization [3] Group 4: Pharmaceutical Membrane Business - The pharmaceutical membrane business was officially launched in 2023, focusing on life health separation and purification [4] - The company has formed a professional team of over 30 members and achieved breakthroughs in key areas such as protein separation and virus removal [4] - Notable applications include a CAR-T cell therapy project with nearly 100% recovery rate of lentivirus and a project that increased the concentration of traditional Chinese medicine exosomes by 20 times while maintaining 100% active ingredients [5] Group 5: Technology Iteration and Market Competitiveness - The company emphasizes technological innovation, achieving a 25% cost reduction in V-MBR equipment and a production speed increase to 20 meters/min for conventional reverse osmosis membranes [5] - The SC series ultra-pure water reverse osmosis membranes have achieved domestic substitution, enhancing international competitiveness [5] - Strategies to improve market share include large-scale production, benchmark project implementation, and promoting high-margin membrane products [5] Group 6: Accounts Receivable Management - The company is actively addressing accounts receivable issues through various measures, including tailored loss reduction plans and establishing a specialized collection team [5] - Efforts have been made to enhance internal management systems and involve local government debt resolution initiatives [5] - Future plans include optimizing collection strategies and improving internal controls to alleviate accounts receivable pressure [5]

Group 1: Company Overview and Strategy - Beijing Beishuiyuan Technology Co., Ltd. is a leading enterprise in the environmental high-tech sector, focusing on water treatment with a comprehensive industrial chain layout that includes membrane material R&D, manufacturing, and digital water management [2]. - The company is currently in a critical transformation phase towards a strategy termed "12256," emphasizing high innovation, intelligence, and environmental sustainability while balancing quality and efficiency [2]. - Traditional business remains stable, while new business areas such as wastewater resource utilization and high-quality drinking water are showing progress [2]. Group 2: Key Projects and Developments - In industrial water treatment, the company has secured multiple key projects, including the Liaoning Lighthouse Economic Development Zone industrial wastewater treatment project and the Liao Yuan High-tech Zone industrial wastewater plant [3]. - The company has achieved a desalination rate of 99.8% with its "UF-RO" dual membrane integration technology, and its annual production capacity for ultra-pure reverse osmosis membranes has reached 1 million square meters, with a maximum capacity of 3 to 7 million square meters [3]. - The Bohai New Area integrated seawater utilization project has a total investment exceeding 100 million yuan, integrating water intake, pretreatment, seawater desalination, and photovoltaic energy storage systems [3]. Group 3: Emerging Business Areas - The company has made significant advancements in lithium extraction from salt lakes, with projects like the 20,000 tons/year lithium hydroxide project using a titanium-based adsorbent and membrane system [3]. - The pharmaceutical membrane business was officially launched in 2023, focusing on protein separation and virus removal, with a professional team of over 30 members [3]. - Current revenue from the pharmaceutical membrane segment is still small, but the company plans to expand its market presence through continuous technological iterations and promotions [3]. Group 4: Technological Innovations and Market Competitiveness - The company has made key breakthroughs in membrane technology iterations and domestic replacements, including the fifth generation of MBR membrane modules and energy-saving membrane bioreactor technology [4]. - The production speed of conventional reverse osmosis membranes has increased to 20 meters per minute due to intelligent upgrades in production lines [4]. - The company has successfully replaced imported products with domestically produced ultra-pure water reverse osmosis membranes, enhancing its market share and profitability [4]. Group 5: Accounts Receivable Management - The company is actively addressing accounts receivable pressures through various measures, including tailored loss reduction plans for different projects and establishing a specialized collection team [4]. - Recent efforts have shown gradual success in recovering long-term accounts receivable, with ongoing strategies to optimize collection processes and enhance internal controls [4].

Group 1: Wastewater Resource Utilization - Wastewater resource utilization is a core business area, focusing on membrane technology iteration and process innovation [2] - The fifth generation of MBR membrane modules has been developed, with significant breakthroughs in structure and nitrogen removal processes [2] - The Meixi Lake wastewater treatment plant, with a design capacity of 250,000 tons/day, is a representative project, recognized as a national green low-carbon benchmark [2] Group 2: Seawater Desalination - The company is expanding into seawater desalination, previously a minor focus, with current technology matching international leaders [3] - The reverse osmosis membrane products achieve a desalination rate of 99.8%, with annual production capacity reaching 3 million square meters [3] - The Bohai New Area integrated seawater utilization project has a total investment exceeding 500 million yuan, aiming to become a new model for seawater desalination in Hebei Province [3] Group 3: Salt Lake Resource Utilization - Salt lake resource utilization is a new focus area, with the development of specialized adsorbents and integrated technologies [4] - The company has launched projects in Tibet and Qinghai, including a lithium extraction project using titanium-based adsorbents [4] - Future plans include expanding from salt lakes to industrial resource recovery, addressing various raw materials [4] Group 4: Biopharmaceutical Applications - The company has entered the biopharmaceutical sector, developing membranes for protein concentration and virus removal [5] - A professional team has been established, achieving breakthroughs in hollow fiber membrane design and manufacturing [5] - Initial applications include projects in CAR-T cell therapy and traditional Chinese medicine, with high recovery rates reported [5]